New Jersey-based Amneal Pharma starts mfg operations for Indian market

The firm already has manufacturing units in four Indian cities, all of which are focused on the export market

Amneal Pharma, Pharmaceuticals
Amneal Pharmaceuticals
BS Reporter
1 min read Last Updated : Oct 10 2022 | 4:12 PM IST
New Jersey-headquartered Amneal Pharmaceuticals, founded by two Indian-American brothers, is now launching commercial operations to cater to the domestic market in India. It already has a manufacturing and R&D footprint focused on exports, with plants in four Indian cities.

To helm its India commercial operations, the company has roped in Shyamakant Giri as Managing Director and President, India Business and Emerging Markets. In this new role, he will be responsible for Amneal's commercial expansion and growth in India, Africa, Gulf, CIS and South Asian markets, the company said.

Amneal has had a presence in India since 2008 but focuses on exports from its plants at Ahmedabad, Dahej, Hyderabad and Vizag. Now, it is entering the domestic market.

Chirag Patel and Chintu Patel, co-chief executive officers of Amneal, said they would focus on the Indian market’s unmet needs. Giri said that Amneal will bring access to global quality medical solutions in India.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :pharmaceutical firmsAmneal PharmaceuticalsPharma sectorPharmaceuticalDomestic marketsindia marketEmerging marketsAhmedabadHyderabadPharma Companies

Next Story